Homebiotech and pharmaceuticalsAlnylam CEO backs inflation-based drug price hikes, welcomes Amazon's foray into health... biotech and pharmaceuticals Alnylam CEO backs inflation-based drug price hikes, welcomes Amazon’s foray into health care By fox news November 30, 2017 0 69 Share Facebook Twitter Pinterest WhatsApp Before the approval of Alnylam's first drug, CEO John Maraganore backed the idea of raising prices pegged to inflation. Maraganore also said he welcomes a conversation with Amazon to disrupt drug distribution. TagsAlnylam Pharmaceuticals IncAmazon.com IncBiotech and PharmaceuticalsHealth care industryTechnology Share Facebook Twitter Pinterest WhatsApp Previous articlePorsche executive talks about keeping up with TeslaNext articleAsia trades mixed after US tax bill vote gets delayed fox newshttp://desifashionista.com RELATED ARTICLES biotech and pharmaceuticals Theranos dodges bankruptcy after $100 million loan: Report December 26, 2017 biotech and pharmaceuticals FDA approves Luxturna gene therapy for rare form of inherited vision loss December 19, 2017 biotech and pharmaceuticals FDA to target ‘potentially harmful, unproven’ homeopathic drugs under new proposal December 18, 2017 LEAVE A REPLY Cancel replyLog in to leave a comment - Advertisment - Most Popular The 10 most in-demand work-from-anywhere jobs companies are hiring for in 2022 September 5, 2022 Stressed about credit card debt? Take these steps to help trim high-interest account balances September 5, 2022 There are only 4 big movie releases left this year — here’s what’s at stake for Hollywood September 5, 2022 CVS to buy home health giant Signify Health for about $8 billion September 5, 2022 Load more